VCEL · Vericel Corp
$44.20
-0.34 (-0.76%)
At close · Aug 14
Market Cap
$2.26B
Shares
51.21M
Vericel Corp Earnings Call Transcripts
Every quarterly earnings call for Vericel Corp (VCEL) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲11.7%
$38.55M
−$6.58M
'22 Q3
22-11-09
▲10.7%
$52.69M
$5.92M
'22 Q4
23-01-10
▲13.7%
$41.02M
−$7.50M
'23 Q1
23-05-10
▲24%
$45.92M
−$5.02M
'23 Q2
23-08-02
▲18.2%
$45.58M
−$3.66M
'23 Q3
23-11-08
▲23.3%
$65.00M
$12.99M
'23 Q4
24-02-29
▲25%
$51.28M
−$3.86M
'24 Q1
24-05-08
▲14.7%
$52.66M
−$4.68M
'24 Q2
24-08-01
▲27%
$57.91M
−$901,000
'24 Q3
24-11-07
▲16%
$75.38M
$19.81M
'24 Q4
25-01-14
▲2.6%
$52.60M
−$11.25M
'25 Q1
25-05-08
▲20.1%
$63.24M
−$553,000
'25 Q2
25-07-31
▲16.6%
$67.50M
$5.07M
'25 Q3
25-11-06
▲23.3%
$92.92M
$23.24M
'25 Q4
26-02-26
▲30.1%
$68.42M
−$6.30M
'26 Q1
26-05-07
LATEST
▲22.5%
$77.46M
$2.21M
'26 Q2
26-07-30
Earnings call
FY26 · Q2
2026-07-30
Vericel Corporation Second Quarter 2026 Earnings Call
Confident tone
Macy franchise growth
Financial outperformance and guidance raise
Burn Care performance
Revenue
$77.46M
▲ 22.5% YoY Diluted EPS
$0.04
Gross margin
72.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-16
Truist Securities MedTech Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-07
Vericel Corp Q1 FY2026 Earnings Call
Confident tone
Macy revenue growth and sales force expansion
BurnCare / Nexabrid BARDA award
Raised full-year 2026 revenue guidance
Revenue
$68.42M
▲ 30.1% YoY Diluted EPS
$-0.12
Gross margin
72.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Vericel Corp Q4 FY2025 Earnings Call
Confident tone
Macy revenue momentum
Macy Arthro
New manufacturing facility
Revenue
$92.92M*
▲ 23.3% YoY Gross margin
78.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Vericel Corp Q3 FY2025 Earnings Call
Confident tone
Macy Arthro Launch
Profitability and Cash Flow
Burn Care / EpiCell / Nexabird
Revenue
$67.50M
▲ 16.6% YoY Diluted EPS
$0.10
Gross margin
73.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-31
Vericel Corp Q2 FY2025 Earnings Call
Confident tone
MACI ankle Phase III and long-term pipeline
EPICEL performance
2025 financial guidance and burn care outlook
Revenue
$63.24M
▲ 20.1% YoY Diluted EPS
$-0.01
Gross margin
73.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Vericel Corp Q1 FY2025 Earnings Call
Confident tone
MACI Core Franchise
MACI Arthro Launch
Epicel Volatility
Revenue
$52.60M
▲ 2.6% YoY Diluted EPS
$-0.23
Gross margin
69.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-01-14
Vericel Corp Q4 FY2024 Earnings Call
Confident tone
MACI franchise growth
Ankle MACI program
2025 financial guidance
Revenue
$75.38M*
▲ 16% YoY Gross margin
77.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Vericel Corp Q3 FY2024 Earnings Call
Confident tone
MACI revenue growth
MACI ankle indication
MACI Arthro launch
Revenue
$57.91M
▲ 27% YoY Diluted EPS
$-0.02
Gross margin
71.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-01
Vericel Corp Q2 FY2024 Earnings Call
Confident tone
MACI franchise growth
NexoBrid launch
Epicel performance variability
Revenue
$52.66M
▲ 14.7% YoY Diluted EPS
$-0.10
Gross margin
69.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-08
Vericel Corp Q1 FY2024 Earnings Call
Confident tone
MACI core performance
Epicel / Burn Care franchise
2024 full-year guidance raise
Revenue
$51.28M
▲ 25% YoY Diluted EPS
$-0.08
Gross margin
68.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-29
Vericel Corp Q4 FY2023 Earnings Call
Confident tone
MACI revenue growth
Burn care franchise and NexoBrid launch
2024 financial guidance
Revenue
$65.00M*
▲ 23.3% YoY Gross margin
74.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-08
Vericel Corp Q3 FY2023 Earnings Call
Revenue
$45.58M
▲ 18.2% YoY Diluted EPS
$-0.08
Gross margin
67.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-02
Vericel Corp Q2 FY2023 Earnings Call
Revenue
$45.92M
▲ 24% YoY Diluted EPS
$-0.11
Gross margin
65.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-10
Vericel Corp Q1 FY2023 Earnings Call
Revenue
$41.02M
▲ 13.7% YoY Diluted EPS
$-0.16
Gross margin
64.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-01-10
Vericel Corp Q4 FY2022 Earnings Call
Revenue
$52.69M*
▲ 10.7% YoY Gross margin
72.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-09
Vericel Corp Q3 FY2022 Earnings Call
Revenue
$38.55M
▲ 11.7% YoY Diluted EPS
$-0.14
Gross margin
65.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-03
Vericel Corp Q2 FY2022 Earnings Call
Revenue
$37.05M
▼ 6.3% YoY Diluted EPS
$-0.19
Gross margin
61.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-04
Vericel Corp Q1 FY2022 Earnings Call
Revenue
$36.07M
▲ 4.4% YoY Diluted EPS
$-0.15
Gross margin
65.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-01-12
Vericel Corp Q4 FY2021 Earnings Call
Revenue
$47.59M*
▲ 5.2% YoY Gross margin
71.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-09
Vericel Corp Q3 FY2021 Earnings Call
Revenue
$34.51M
▲ 7% YoY Diluted EPS
$-0.11
▼ 237.5% YoY Gross margin
64.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-04
Vericel Corp Q2 FY2021 Earnings Call
Revenue
$39.52M
▲ 97.5% YoY Diluted EPS
$-0.08
Gross margin
68.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-05
Vericel Corp Q1 FY2021 Earnings Call
Revenue
$34.57M
▲ 29.6% YoY Diluted EPS
$-0.07
Gross margin
66.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-01-11
Vericel Corp Q4 FY2020 Earnings Call
Revenue
$45.23M
▲ 14.8% YoY Diluted EPS
$0.25
▲ 25% YoY Gross margin
74.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-14
Vericel Corp Q3 FY2020 Earnings Call
Revenue
$32.26M
▲ 5.8% YoY Diluted EPS
$0.08
▲ 14.3% YoY Gross margin
69.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-05
Vericel Corp Q2 FY2020 Earnings Call
Revenue
$20.01M
▼ 23.5% YoY Diluted EPS
$-0.18
Gross margin
56.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-02
Vericel Corp Q1 FY2020 Earnings Call
Revenue
$26.68M
▲ 22.3% YoY Diluted EPS
$-0.10
Gross margin
62.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-25
Vericel Corp Q4 FY2019 Earnings Call
Revenue
$39.39M
▲ 25.7% YoY Diluted EPS
$0.20
▲ 81.8% YoY Gross margin
73.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–28 of 28 earnings calls
Key facts
CIK
887359
CUSIP
92346J108
13F (30d)
300 filings
299 filers
Visit website
Investor relations